Katherine Stueland is an executive with over 20 years of experience in the healthcare sector. She is known for transforming healthcare through strategic growth, patient advocacy, and the commercialization of groundbreaking diagnostics and therapeutics. Stueland has a track record of scaling precision medicine companies, building high-impact teams, and fostering relationships with investors, clinicians, and patient communities.

She holds the title of CEO and serves as a Board Member.